Agonist Versus Classical HCG Trigger (Poor Responders, Normoresponders and High Responders)

• Status: Unknown status
• Trial end date: 2018-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

Agonist triggering in controlled ovarian stimulation protocols is being used during last years (among high responder patients to avoid OHSS).

Indeed, agonist triggering is more physiologic than HCG triggering. Investigators propose to compare the effectiveness of both types of trigger among three different subsets of patients:

1. Poor responders.

2. Normo-responders

3. High responders Comparing both the number and the quality of achieved oocytes.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ginegorama S.L.
• Treatments: Chorionic Gonadotropin; Hormones

Criteria

Inclusion Criteria:

• Women scheduled for IVF treatment.

• First ovarian stimulation

• Two ovaries present

• No previous ovarian surgery

• No contraindication for any of the assigned treatments

Exclusion Criteria:

• Previous ovarian surgery.

• Previous IVF treatments.

• Absence of one ovary

• Presence of an endometrioma